Urinary tract infections (UTIs) are one of the most common reasons for antibiotic prescriptions. However, many of these prescriptions are unnecessary because standard lab tests take days to identify the bacteria. This delay leads doctors to prescribe broad-spectrum antibiotics, which fuels antibiotic resistance.
A recent review looked at new rapid diagnostic tests that can identify the bacteria causing a UTI in hours instead of days. These tests can also tell which antibiotics will work, allowing doctors to prescribe the right drug from the start. This approach, called targeted therapy, could reduce the use of broad-spectrum antibiotics and help slow the rise of resistant bacteria.
Despite the promise of these tests, the review found several barriers to their use. The tests are often expensive, and insurance companies may not cover them. In addition, clinics and hospitals may not have the equipment or training to use them. Policy changes and better integration into routine care are needed to make these tests widely available.
The review concludes that bridging the gap between new diagnostic tools and everyday medical practice is essential for making progress against antibiotic resistance. Without addressing cost, policy, and implementation challenges, even the best tests will not reach the patients who need them.
